RENAL VASCULAR RESPONSIVENESS TO ARACHIDONIC-ACID IN EXPERIMENTAL DIABETES

被引:29
作者
QUILLEY, J
MCGIFF, JC
机构
[1] Department of Pharmacology, New York Medical College, Valhalla
关键词
D O I
10.1111/j.1476-5381.1990.tb15805.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Isolated perfused kidneys from diabetic rats (duration 4-6 and 20-24 weeks) were more sensitive to the vasoconstrictor effects of arachidonic acid than kidneys from age-matched control rats. Sensitivity diminised with age in both control and diabetic groups. The enhanced vasoconstrictor effect of arachidonic acid in diabetic rat kidneys was associated with increased conversion to prostaglandins. The renal vasoconstrictor response to arachidonic acid in both groups was reduced by thromboxane A2/prostaglandin H2 receptor antagonism but not by inhibition of thromboxane synthase. Diabetic rat kidneys were also more sensitive to the vasoconstrictor effects of the endoperoxide analogue, U46619, while vasoconstrictor responses to phenylephrine were not markedly different from those of control rat kidneys. In conclusion, prostaglandin endoperoxides appear to mediate arachidonic acid-induced vasoconstriction in diabetic and control rat kidneys. The enhanced renal vasoconstrictor response to arachidonic acid in diabetic rats results from increased sensitivity to endoperoxides and increased formation of endoperoxides from arachidonic acid.
引用
收藏
页码:336 / 340
页数:5
相关论文
共 14 条
[1]   CHANGES IN CARDIOVASCULAR SENSITIVITY OF ALLOXAN-TREATED DIABETIC RATS TO ARACHIDONIC-ACID [J].
BOURA, ALA ;
HODGSON, WC ;
KING, RG .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 89 (03) :613-618
[2]  
HALUSHKA PV, 1981, J LAB CLIN MED, V97, P87
[3]   DECREASED VASCULAR PROSTACYCLIN IN EXPERIMENTAL DIABETES [J].
HARRISON, HE ;
REECE, AH ;
JOHNSON, M .
LIFE SCIENCES, 1978, 23 (04) :351-356
[4]  
JOHNSON M, 1979, LANCET, V1, P325
[5]   ROLE OF ENDOPEROXIDES IN ARACHIDONIC ACID-INDUCED VASOCONSTRICTION IN THE ISOLATED PERFUSED KIDNEY OF THE RAT [J].
QUILLEY, J ;
MCGIFF, JC ;
NASJLETTI, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (01) :111-116
[6]  
QUILLEY J, 1985, J PHARMACOL EXP THER, V234, P211
[7]  
REINECK HJ, 1983, KIDNEY INT, V23, pA247
[8]   INFLUENCE OF STREPTOZOTOCIN DIABETES ON MYOCARDIAL LIPIDS AND PROSTAGLANDIN RELEASE BY THE RAT-HEART [J].
ROSEN, P ;
SENGER, W ;
FEUERSTEIN, J ;
GROTE, H ;
REINAUER, H ;
SCHROR, K .
BIOCHEMICAL MEDICINE, 1983, 30 (01) :19-33
[9]  
ROTH DM, 1983, DIABETOLOGIA, V24, P374
[10]   RENAL VASCULAR-RESPONSES AND EICOSANOID RELEASE IN DIABETIC RATS [J].
SARUBBI, D ;
MCGIFF, JC ;
QUILLEY, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (05) :F762-F768